Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.34down ₹0.19 (1.80%)BSE ₹10.36
Share price at the NSE close on 28 Oct 2026. Previous close ₹10.53.
28 Oct: open ₹10.58, high ₹10.75, low ₹10.11
52-week range of traded prices to 28 Oct 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹201 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.35
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,29,85665.4% delivered
Nectar Lifesciences board and management
56 filed, newest first. Page 1 of 2.
Aug 2026
6 Aug · Management
Nov 2025
11 Nov · Management
Oct 2025
27 Oct · Management
Apr 2025
Feb 2025
Nov 2024
Sep 2024
Jan 2024
Dec 2022
Nov 2022
Sep 2022
Aug 2022
Jul 2022
May 2022
Jul 2021
Jun 2021
Feb 2021
Jun 2019
Feb 2019
Nov 2018
Jun 2018
28 Jun · Management
Nov 2017
Dec 2015
Oct 2015
Mar 2015
Feb 2015
Jan 2015
Nov 2014
Aug 2014
11 Aug · Management
Export Import Bank of India has appointed Ms. Rima Marphatia as their nominee director on the Board of Directors of the company. The appointment of Ms. Rima Marphatia is also satisfy the requirement of appointment of woman director on the Board as per section 149 (1) of the Companies Act, 2013.
Feb 2014
Oct 2013
15 Oct · Management
Board of Directors through resolution by circulation, on October 14, 2013 have appointed Mr. Dinesh Dua on the Board as an Additional Director as well as Wholetime Director (designated as Chief Executive Officer) for a period of 5 years w.e.f October 14, 2013, subject to the approval of shareholders in their General Meeting.
Nov 2012
1 Nov · Management
Board of Directors on November 01, 2012 has appointed Mr. Harparkash Singh Gill on the Board as Wholetime Director [designated as President (Operation) & Director] for a period of three years w.e.f. November 01, 2012, subject to approval of shareholders.
Jul 2012
31 Jul · Management
Mr. Dinesh Dua has resigned as Chief Executive Officer and Director from the company w.e.f. July 31, 2012.
May 2012
14 May · Management
Board of Directors of the Company in their meeting held on May 14, 2012 have re-appointed Mr. Sanjiv Goyal as an Chairman & Managing Director of the Company for a period of 5 years from June 01, 2012.
Nov 2010
9 Nov · Management
Board of Directors of the Company in their meeting held on November 08, 2010 have re-appointed Mr. Aryan Goyal as an Executive Director of the company for a period of 5 years from December 05, 2010.
Aug 2010
12 Aug · Management
Board of Directors in their Meeting held on August 11, 2010 have appointed: 1) Mr. Saurabh Goyal on the Board as an Executive Director for a period of five years w.e.f. August 11, 2010 subject to the approval of shareholders in their General Meeting. 2) Mr. Ajay Swaroop on the Board as an Additional Director (Independent Director) of the Company who shall hold the office upto the date of next Annual General Meeting.
Feb 2010
22 Feb · Management
Board of Directors in their meeting held on February 19, 2010 have appointed: 1) Mr. Shamsher Singh Chauhan on the Board as an Additional Director. 2) Mr. Raman Kapur on the Board as an Additional Director.22 Feb · Management
Board of Directors through resolution by circulation on February 18, 2010 have appointed: 1) Mr. Vivek Sett on the Board as an Additional Director.
Feb 2009
11 Feb · Management
Mr. Saurabh Goyal has resigned from directorship of the company w.e.f. 11.02.2009 and consequently also ceased to be Wholetime Director of the Company
Dec 2008
1 Dec · Management
Board of Directors through resolution by circulation on November 28, 2008 have appointed Mr. Dinesh Dua on the Board as an Additional Director as well as Wholetime Director (designated as Chief Executive Officer) for a period of Five Years w.e.f. November 28, 2008, subject to the approval of shareholders in their General Meeting.
Jun 2008
20 Jun · Management
The Board of Directors in their Meeting held on June 20, 2008 have appointed Mr. Saurabh Goyal on the Board as an Executive Director for a period of five years w.e.f June 20, 2008, subject to the approval of shareholders in their General Meeting. Further Mrs Raman Goyal has resigned from directorship of the company w.e.f June 20, 2008 and consequently also ceased to Wholetime Director of the company. The Board, while taking note of the resignation, placed on record its sincere gratitude for the services rendered by Mrs Raman Goyal as Director as well as Wholetime Director.